MICHELA KAMINSKI: Open Payments
NPI 1861917080 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,351 in 87 payments from 14 companies in 2025. Trend: 2023 $769 · 2024 $1,618 · 2025 $1,351
Food & beverage: $1,215Education: $136
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 18 | $277 |
| ABBVIE INC. | 21 | $272 |
| UCB, Inc. | 16 | $148 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 8 | $139 |
| GENZYME CORPORATION | 6 | $120 |
| Incyte Corporation | 5 | $103 |
| Janssen Biotech, Inc. | 3 | $99 |
| Janssen Scientific Affairs, LLC | 1 | $72 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Organon LLC | 3 | $25 |
Products named: OTEZLA, SKYRIZI, TREMFYA, Bimzelx, DUPIXENT, OPZELURA, RINVOQ, ILUMYA.
Industry payments across NY — which companies pay providers there.
